<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of the work was to identify risk factors of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) in 151 patients with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (MS, IDF 2005); 88 of them presented with the recurrent form of AE 63 had no <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Practically <z:hpo ids='HP_0000001'>all</z:hpo> patients suffered from arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The groups were comparable in terms of age, concomitant disorders, AH duration, arterial pressure, and severity of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with permanent AF, hemodynamically significant <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e>, <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> with wave Q in the medical history, and cardiac <z:hpo ids='HP_0002617'>aneurysm</z:hpo> were excluded from the study </plain></SENT>
<SENT sid="4" pm="."><plain>We evaluated anthropometric parameters, carbohydrate and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism, daily <z:mp ids='MP_0002871'>albuminuria</z:mp>, results of echoCG, and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with AF had worse anthropometric and metabolic parameters and more pronounced remodeling of myocardium with <z:e sem="disease" ids="C1273070" disease_type="Disease or Syndrome" abbrv="">left ventricular diastolic dysfunction</z:e>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e>, and renal lesions than patients with MS without AF Patients with MS having abdominal <z:hpo ids='HP_0001513'>obesity</z:hpo> and AH over 10 years, marked <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (IR index higher than 2.77), reduced <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> level (below 1.1 mmol/l), <z:mp ids='MP_0004063'>left atrial dilation</z:mp> (end diastolic size &gt;43mm), <z:mp ids='MP_0002871'>albuminuria</z:mp> &gt;60 mg/d, waist circumference &gt;104 cm were at high risk of AF (prognostically unfavourable <z:hpo ids='HP_0011675'>arrhythmia</z:hpo>) </plain></SENT>
<SENT sid="6" pm="."><plain>It is concluded that dynamic observation of the above MS and echo-CG parameters, and <z:mp ids='MP_0002871'>albuminuria</z:mp> coupled to the adequate correction of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, control of AH and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> is important for the prevention of <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo> </plain></SENT>
</text></document>